Cite
HARVARD Citation
Ben‐Horin, S. et al. (2017). Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab? Authors' reply. Alimentary pharmacology & therapeutics. 45 (5), pp. 760-762. [Online].